Our 325,000ft² facility can manufacture up to 3 billion units. We supply oral pharmaceuticals to the U.S. market using our expertise in controlled release granules, serialization, blister and bottle packaging, powder packaging in stick packs, fluid bed operations, solvent processing, DEA controlled substances, high potency active ingredients and nanoparticle milling.

A culture of caring, innovation & quality
EXTRAORDINARY CARE


Integrated development &
manufacturing services


Quality by design for oral dosage forms
Clinical trials materials to process validation

High capacity oral solid dose
Serialization ready packaging

Clinical materials / packaging with
complex kit assembly
OUR CAPABILITIES
Formulation Services
Our services allow us to create stable, effective drug delivery platforms. Our clients are able to achieve the optimum dosage form needed for faster commercialization.
Analytical Services
Demonstrating experience, efficiency and
technical proficiency in the development and
validation of analytical methodology, stability
and storage support and GMP testing
services.
Product Development
By utilizing our expertise in formulation
development and technology transfer,
Frontida challenges the industry standard.
Offering immediate and modified release oral
solid dose, liquids, and suspensions.
Contract Manufacturing
Our broad spectrum of manufacturing
equipment and know-how provide innovative
solutions for everything from traditional
proprietary technologies, clinical trial
materials, and commercial production goods.

Frontida is a contract development and
manufacturing organization that works
collaboratively with clients to bring
products to the pharmaceutical market.
We offer formulation, analytical method
development and validation, process
development, commercial manufacturing packaging
and more.
We strive to improve the pharmaceutical
and biotechnology industries by working
with scientists who are dedicated to
coming up with the best solutions
for clients and patients. Our team is
also extensively experienced in the
development and manufacturing of oral
dosage forms, including tablets and
capsules.
MEET OUR TEAM
Learn more about Frontida through the expertise
and insight from our management team.

DuraGran®
Our fluid bed processing technology reduces production times by combining particle sizing and coating processes together, eliminating the need for extrusion and spheronization for high API-loaded drug particulates.
AdaptDose™
Our unique commercialized approach to adaptive formulation design provides the ability to combine multiple active ingredients and/or delivery rates in a single capsule using minitabs, beads, granules and liquids. Also appropriate for dose escalation studies.
DISCUSS YOUR REQUIREMENTS
Team Member Perspectives
I have been working in the pharmaceutical industry in various departments of manufacturing for 30 years. I am very excited and privileged to work with the new team formed by Frontida BioPharm. I am committed to portray the Frontida motto of caring for our clients by maintaining a high level of quality products and services for each of our customers.

Mirza Javid Baig
Associate Director - Manufacturing
We are highly motivated and determined to provide the highest quality products. I am proud to be a Frontida employee, working amongst a great team of caring, committed people. I look forward to new business opportunities and exciting challenges in the road ahead.

Diane Reed
Associate Director - Document Control
Frontida brings new life to its employees with positive motivation and improvements. New management is constantly adapting new ideas to improve the quality of our work.

Kirit Patel
Director - Quality Assurance
Working for Frontida is a pleasure. We are all working towards the same goal: to support our clients and make quality products for the consumers who need the medications made at the site.

Arne Kauffman
Manager - IT GxP System Support
NEWS & UPDATES
Frontida BioPharm, Inc. Announces Highly Potent Compound Contract Manufacturing Suite to Support Existing Product Development and Manufacturing Capabilities
Highly potent compounds serve an increasingly significant role in numerous R&D landscapes and pharmaceutical intensive medical treatments; i.e. oncology, atrial fibrillation, osteoporosis.
FB-HRS, LLC Announces US FDA Clearance of IND Application to Initiate Clinical Trial for FBHRS001, a Treatment for Atrial Fibrillation
Atrial Fibrillation impacts a tremendous amount of people around the world and current treatment options are underwhelming due to negative side effects. FB–HRS, LLC has developed a treatment that may reduce those undesired consequences.